Skip to content

Clinical trials

Observational Ocular Hypertension trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ocular Hypertension Phase: Observational Country / region: United States Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20041
20062
20082
20092
20123
20143
20151
20171
20181
20191
20212
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting4
Terminated3
Unknown status3
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan5
National Eye Institute (NEI)3
University of Colorado, Denver3
Glaukos Corporation2
Alcon Research1
Brian Shafer1
Duke University1
ForSight Vision5, Inc.1
Glaucoma Research & Education Group1
Iantrek, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ocular Hypertension29
Glaucoma, Open-Angle21
Glaucoma14
Low Tension Glaucoma3
Aniridia1
Cataract1
Congenital Abnormalities1
Dry Eye Syndromes1
Exfoliation Syndrome1
Eye Abnormalities1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.